Lipella Pharmaceuticals (LIPO) Competitors $0.77 -0.02 (-2.09%) As of 11:35 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LIPO vs. MTEX, CARM, LPCN, HOTH, LEXX, ATHA, ALLR, ASBP, SYBX, and EDSAShould you be buying Lipella Pharmaceuticals stock or one of its competitors? The main competitors of Lipella Pharmaceuticals include Mannatech (MTEX), Carisma Therapeutics (CARM), Lipocine (LPCN), Hoth Therapeutics (HOTH), Lexaria Bioscience (LEXX), Athira Pharma (ATHA), Allarity Therapeutics (ALLR), Aspire Biopharma (ASBP), Synlogic (SYBX), and Edesa Biotech (EDSA). These companies are all part of the "pharmaceutical products" industry. Lipella Pharmaceuticals vs. Its Competitors Mannatech Carisma Therapeutics Lipocine Hoth Therapeutics Lexaria Bioscience Athira Pharma Allarity Therapeutics Aspire Biopharma Synlogic Edesa Biotech Mannatech (NASDAQ:MTEX) and Lipella Pharmaceuticals (NASDAQ:LIPO) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, institutional ownership, valuation, earnings, risk, profitability and dividends. Which has more risk & volatility, MTEX or LIPO? Mannatech has a beta of 0.89, suggesting that its stock price is 11% less volatile than the S&P 500. Comparatively, Lipella Pharmaceuticals has a beta of -0.08, suggesting that its stock price is 108% less volatile than the S&P 500. Which has preferable valuation & earnings, MTEX or LIPO? Mannatech has higher revenue and earnings than Lipella Pharmaceuticals. Mannatech is trading at a lower price-to-earnings ratio than Lipella Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMannatech$115.04M0.13$2.49M-$0.10-79.50Lipella Pharmaceuticals$536.36K6.43-$5.02M-$4.08-0.19 Do institutionals and insiders hold more shares of MTEX or LIPO? 13.0% of Mannatech shares are held by institutional investors. Comparatively, 74.3% of Lipella Pharmaceuticals shares are held by institutional investors. 41.5% of Mannatech shares are held by company insiders. Comparatively, 32.1% of Lipella Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media prefer MTEX or LIPO? In the previous week, Mannatech had 1 more articles in the media than Lipella Pharmaceuticals. MarketBeat recorded 1 mentions for Mannatech and 0 mentions for Lipella Pharmaceuticals. Mannatech's average media sentiment score of 1.87 beat Lipella Pharmaceuticals' score of 0.00 indicating that Mannatech is being referred to more favorably in the media. Company Overall Sentiment Mannatech Very Positive Lipella Pharmaceuticals Neutral Is MTEX or LIPO more profitable? Mannatech has a net margin of -0.19% compared to Lipella Pharmaceuticals' net margin of -988.83%. Mannatech's return on equity of -2.56% beat Lipella Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Mannatech-0.19% -2.56% -0.57% Lipella Pharmaceuticals -988.83%-224.08%-172.88% SummaryMannatech beats Lipella Pharmaceuticals on 10 of the 13 factors compared between the two stocks. Get Lipella Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LIPO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LIPO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIPO vs. The Competition Export to ExcelMetricLipella PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.45M$2.92B$5.56B$9.30BDividend YieldN/A2.43%4.23%4.03%P/E Ratio-0.1920.3528.6119.64Price / Sales6.43304.32437.49188.30Price / CashN/A43.1536.0257.93Price / Book0.497.718.185.63Net Income-$5.02M-$55.11M$3.23B$257.73M7 Day Performance-3.49%0.68%-0.25%0.07%1 Month Performance-73.10%8.22%5.40%8.32%1 Year Performance-78.98%-2.64%26.35%13.78% Lipella Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIPOLipella Pharmaceuticals1.6253 of 5 stars$0.77-2.1%N/A-79.3%$3.45M$536.36K-0.194Gap UpMTEXMannatech1.3706 of 5 stars$8.83-4.0%N/A+14.8%$16.78M$117.87M-88.30250Positive NewsGap DownCARMCarisma Therapeutics3.0084 of 5 stars$0.40+0.5%$1.93+385.0%-67.5%$16.59M$19.63M-0.2520Positive NewsLPCNLipocine3.0093 of 5 stars$3.10-0.3%$9.00+190.3%-58.0%$16.59M$3.67M-3.0410HOTHHoth Therapeutics3.273 of 5 stars$1.24+5.1%$4.00+222.6%+52.3%$16.38MN/A-1.094LEXXLexaria Bioscience1.9482 of 5 stars$0.89+1.7%$5.00+462.1%-72.0%$15.62M$460K-1.517ATHAAthira Pharma3.4466 of 5 stars$0.39+18.1%$11.25+2,784.6%-88.2%$15.23MN/A-0.1940ALLRAllarity Therapeutics0.5795 of 5 stars$0.99+0.7%N/A-83.1%$14.93MN/A0.0010News CoverageASBPAspire BiopharmaN/A$0.30+5.0%N/AN/A$14.86MN/A0.00N/AGap UpSYBXSynlogic1.1411 of 5 stars$1.26+5.9%N/A-14.3%$14.74M$10K-0.5080Positive NewsGap UpEDSAEdesa Biotech2.2445 of 5 stars$2.09+1.5%$5.00+139.2%-48.5%$14.67MN/A-1.3120 Related Companies and Tools Related Companies MTEX Competitors CARM Competitors LPCN Competitors HOTH Competitors LEXX Competitors ATHA Competitors ALLR Competitors ASBP Competitors SYBX Competitors EDSA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LIPO) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredAll New Social Security Numbers coming July 23?To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lipella Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lipella Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LIPO Stock Alerts